EVH Q3'26 Earnings: EPS estimate is 0.06 USD

What happened

Evolent Health is scheduled to announce its third-quarter 2026 results on November 5 before the market opens, with disclosure expected at 9:30 a.m. ET. The supplied estimates are revenue of $727.06 million and earnings per share of $0.06.

Confirmed

Global impact / market context

The results will show whether reported revenue and earnings match the supplied expectations. Revenue influences the resources available to cover operating costs, while earnings per share, a company’s profit divided by its shares, helps investors judge profitability; a shortfall could weaken confidence in those expectations.

Analyst inference

The table shows earlier quarters had both positive and negative differences between reported and estimated results, including swings in revenue and earnings per share. This history makes the upcoming comparison relevant, but the article provides no share-price reaction or explanation for past differences.

Confirmed

What to watch

1. Check the November 5 announcement for reported revenue against the $727.06 million estimate; the comparison will show whether sales met the stated expectation. Confirmed
2. Compare reported earnings per share with the $0.06 estimate; earnings per share means profit divided across shares, and a miss would indicate weaker profit than expected. Analyst inference
3. Look for management’s explanation of results and any updated outlook, especially details on costs or revenue that could change expectations for future performance. Analyst inference

Evidence

• Original source link unavailable